Lead:  KU LEUVEN

Aim: Analyse the existing regulatory framework governing stakeholder engagement in cancer research biobanking across the EU, considering the recent regulatory developments, such as the EHDS and the AI Act.

Methods:

• Comparative legal analysis in 5 countries

• Mapping regulations (e.g. AI Act and EHDS)